Literature DB >> 4704518

Effect of fenfluramine on human growth hormone release.

W R Sulaiman, R H Johnson.   

Abstract

In order to investigate the effect of fenfluramine on hormonal and metabolic changes with exercise, five normal volunteers have been studied during and after 20 minutes of steady exercise on a bicycle ergometer after injection of fenfluramine (20 mg intravenously). Fenfluramine abolished the rise of plasma human growth hormone (HGH) which occurred in control investigations. Fenfluramine also affected plasma insulin, blood glucose, and ketone body levels.The acute effect of fenfluramine on the release of growth hormone was examined further by studying its effect in patients with acromegaly. A marked depression of growth hormone occurred both at rest and with exercise. These observations indicate that fenfluramine has a direct effect on pathways controlling growth hormone release. We also suggest that this action may have practical use in the medical treatment of acromegaly.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4704518      PMCID: PMC1589327          DOI: 10.1136/bmj.2.5862.329

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  21 in total

1.  Effect of fenfluramine on blood-lipids in man.

Authors:  G L Pawan
Journal:  Lancet       Date:  1969-03-08       Impact factor: 79.321

2.  Growth hormone dynamics in acromegaly.

Authors:  A M Lawrence; I D Goldfine; L Kirsteins
Journal:  J Clin Endocrinol Metab       Date:  1970-09       Impact factor: 5.958

3.  Treatment of refractory obesity with fenfluramine.

Authors:  J F Munro; D A Seaton; L J Duncan
Journal:  Br Med J       Date:  1966-09-10

4.  A clinical trial of fenfluramine.

Authors:  J B Traherne
Journal:  Practitioner       Date:  1965-11

5.  Regulation of growth hormone secretion in acromegaly.

Authors:  P E Cryer; W H Daughaday
Journal:  J Clin Endocrinol Metab       Date:  1969-03       Impact factor: 5.958

6.  Studies on the site of action of a new anorectic agent, fenfluramine.

Authors:  M H Foxwell; W H Funderburk; J W Ward
Journal:  J Pharmacol Exp Ther       Date:  1969-01       Impact factor: 4.030

7.  Adrenergic receptor control mechanism for growth hormone secretion.

Authors:  W G Blackard; S A Heidingsfelder
Journal:  J Clin Invest       Date:  1968-06       Impact factor: 14.808

8.  Effect of levodopa (L-DOPA) on human hypophyseal tropic hormone release.

Authors:  R L Eddy; A L Jones; Z H Chakmakjian; M C Silverthorne
Journal:  J Clin Endocrinol Metab       Date:  1971-10       Impact factor: 5.958

9.  Influence of amphetamines on plasma corticosteroid and growth hormone levels in man.

Authors:  G M Besser; P W Butler; J Landon; L Rees
Journal:  Br Med J       Date:  1969-11-29

10.  Action of fenfluramine on monoamine stores of rat tissues.

Authors:  E Costa; A Groppetti; A Revuelta
Journal:  Br J Pharmacol       Date:  1971-01       Impact factor: 8.739

View more
  2 in total

1.  Metabolic effects of fenfluramine in obese diabetics.

Authors:  S Larsen; L Vejtorp; P Hornnes; H Bechgaard; L Sestoft; J Lyngsoe
Journal:  Br J Clin Pharmacol       Date:  1977-10       Impact factor: 4.335

Review 2.  Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1975       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.